SkyOak Wealth’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

SkyOak Wealth’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-104,820	Closed	-$398K	–	268
2020 Q1	$398K	Sell	104,820 -12,852	-11%	-$55.4K	0.2%	117
2019 Q4	$599K	Buy	+117,672	New	+$622K	0.19%	129

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

SkyOak Wealth's PGNX Position: Q2 2020 in Review

SkyOak Wealth sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 104,820 shares — an estimated $398K sold.

SkyOak Wealth first reported a position in PGNX in Q4 2019 and held it in 2 quarters. The position peaked at $599K in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

SkyOak Wealth reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
SkyOak Wealth sold 104,820 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $398K.
SkyOak Wealth first reported a position in Progenics Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
SkyOak Wealth's Progenics Pharmaceuticals Inc position peaked at $599K in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on SkyOak Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.